Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAMK2A | Q9UQM7 | 6/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.49 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.46 |
| ▸ | LCK | P06239 | 1/20 | 0.46 |
| ▸ | FYN | P06241 | 1/20 | 0.46 |
| ▸ | GRB2 | P62993 | 1/20 | 0.46 |
| ▸ | EGFR | P00533 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30745400 | 1.00 | CAMK2A (0.51) | CAMK2AALDH1A1LMNAGLACYP2C9 | |
| SCHEMBL1644783 | 0.84 | EGFR (0.49) | CAMK2AALDH1A1LMNAGLACYP2C9 | |
| SCHEMBL10479066 | 0.82 | PTGDR2 (0.42) | ALDH1A1LMNAGLACYP2C9HPGD | |
| SCHEMBL29710650 | 0.82 | PTGDR2 (0.42) | ALDH1A1LMNAGLACYP2C9HPGD | |
| SCHEMBL156238 | 0.81 | TYR (0.60) | CAMK2AALDH1A1LMNAGLACYP2C9 | |
| SCHEMBL29419312 | 0.81 | TYR (0.60) | CAMK2AALDH1A1LMNAGLACYP2C9 | |
| SCHEMBL27743914 | 0.81 | POLB (0.50) | NPSR1POLB | |
| SCHEMBL4047837 | 0.78 | KEAP1 (0.50) | CAMK2ACYP2C9AKR1B1 | |
| SCHEMBL909444 | 0.78 | PKM (0.53) | TSHRAKR1B1 | |
| SCHEMBL2729900 | 0.78 | HPGD (0.42) | CAMK2AALDH1A1LMNACYP2C9HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104447646-B | A kind of method complete synthesis for natural product Moracin M | 中科院广州化学有限公司 | 2016-08-31 | — | — | CN | claimed |
| EP-4692059-A1 | CATIONIC LIPID HAVING DISULFIDE BOND | Tohoku University (JP) | 2026-02-11 | — | — | EP | disclosed |
| EP-4461355-A2 | BENZIMIDAZOYL GLP-1 RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE | Carmot Therapeutics, Inc. (US) | 2024-11-13 | — | — | EP | disclosed |
| WO-2024203577-A1 | CATIONIC LIPID HAVING DISULFIDE BOND | 国立大学法人東北大学 | 2024-10-03 | — | — | WO | disclosed |
| US-20240262811-A1 | BENZIMIDAZOYL GLP-1 RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE | CARMOT THERAPEUTICS, INC. | 2024-08-08 | — | — | US | disclosed |
| EP-4334304-A1 | BENZIMIDAZOYL GLP-1 RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE | Carmot Therapeutics, Inc. (US) | 2024-03-13 | — | — | EP | disclosed |
| CN-117545748-A | Benzimidazolyl GLP-1GPCR receptor agonists, pharmaceutical compositions comprising the same, and methods of use thereof | 卡莫特医疗有限公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-115181082-B | Synthetic method of natural molecule Moracin M | 江苏集萃分子工程研究院有限公司 | 2023-11-03 | — | — | CN | disclosed |
| CN-113121485-B | 3-aryl coumarin derivative and preparation method and application thereof | 中山大学 | 2023-01-03 | — | — | CN | disclosed |
| US-20220396569-A1 | BENZIMIDAZOYL GLP-1 RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE | CARMOT THERAPEUTICS, INC. | 2022-12-15 | — | — | US | disclosed |
| EP-2649062-A1 | BICYCLIC COMPOUNDS AS INHIBITORS OF ACETYL-COA CARBOXYLASE (ACC) | Takeda Pharmaceutical Company Limited (JP) | 2013-10-16 | — | — | EP | disclosed |
| CN-103347872-A | Bicyclic compound | TAKAEDA CHEMICAL IND LTD | 2013-10-09 | — | — | CN | disclosed |
| WO-2012074126-A9 | BICYCLIC COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-06-06 | — | — | WO | disclosed |
| US-20120142714-A1 | BICYCLIC COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-06-07 | — | — | US | disclosed |
| WO-2012074126-A1 | BICYCLIC COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-06-07 | — | — | WO | disclosed |
| CN-1882524-A | 4- ((phenoxyalkyl) thio) -phenoxyacetic acids and analogs | JANSSEN PHARMACEUTICA NV (BE) | 2006-12-20 | — | — | CN | disclosed |
| EP-0582908-B1 | 2-Substituted quinolylmethoxy-phenylacetic acid- and -benzylacyl derivatives, process for their preparation and their use as inhibitors of leukotriene synthesis | BAYER AG (DE) | 1998-05-27 | — | — | EP | disclosed |
| US-5597833-A | LEUKOTRIENE SYNTHESIS INHIBITORS FOR ANTIINFLAMMATORY AGENTS, RESPIRATORY SYSTEM DISORDERS, ANTIALLERGENS OR ANTIISCHEMIC AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1997-01-28 | — | — | US | disclosed |
| CN-1087337-A | The quinolin-2-ylmethoxy phenylacetic acid derivatives that replaces | BAYER AG (DE) | 1994-06-01 | — | — | CN | disclosed |
| EP-0582908-A1 | 2-Substituted guinolylmethoxy-phenylacetic acid derivatives, process for their preparation and their pharmaceutical use | BAYER AG (DE) | 1994-02-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220396569-A1 | BENZIMIDAZOYL GLP-1 RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE | GLP1R, GIPR, GCGR | CAMK2A 2434/4885ALDH1A1 3087/4885LMNA 1687/4885 |
| US-20120142714-A1 | BICYCLIC COMPOUND | ACACA, ACACB, FABP4 | CAMK2A 1494/4885ALDH1A1 172/4885LMNA 3226/4885 |
| US-20240262811-A1 | BENZIMIDAZOYL GLP-1 RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE | GLP1R, GIPR, GCGR | CAMK2A 2434/4885ALDH1A1 3087/4885LMNA 1687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.